PT1632232E - Sal de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]- 2-pirimidinil]amino]benzonitrilo - Google Patents

Sal de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]- 2-pirimidinil]amino]benzonitrilo Download PDF

Info

Publication number
PT1632232E
PT1632232E PT05108086T PT05108086T PT1632232E PT 1632232 E PT1632232 E PT 1632232E PT 05108086 T PT05108086 T PT 05108086T PT 05108086 T PT05108086 T PT 05108086T PT 1632232 E PT1632232 E PT 1632232E
Authority
PT
Portugal
Prior art keywords
amino
dimethylphenyl
pyrimidinyl
cyanooethenyl
benzonitryl
Prior art date
Application number
PT05108086T
Other languages
English (en)
Portuguese (pt)
Inventor
Roger Petrus Gerebern Vandecruys
Jozef Peeters
Paul Theodoor Agnes Stevens
Alfred Elisabeth Stappers
Alex Herman Copmans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38091637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1632232(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from MYPI20043578A external-priority patent/MY169670A/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT1632232E publication Critical patent/PT1632232E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Hybrid Cells (AREA)
PT05108086T 2004-09-02 2005-09-02 Sal de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]- 2-pirimidinil]amino]benzonitrilo PT1632232E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MYPI20043578A MY169670A (en) 2003-09-03 2004-09-02 Combinations of a pyrimidine containing nnrti with rt inhibitors
PCT/EP2004/052028 WO2005021001A1 (en) 2003-09-03 2004-09-03 Combinations of a pyrimidine containing nnrti with rt inhibitors
EP05101467 2005-02-25

Publications (1)

Publication Number Publication Date
PT1632232E true PT1632232E (pt) 2011-08-02

Family

ID=38091637

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05108086T PT1632232E (pt) 2004-09-02 2005-09-02 Sal de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]- 2-pirimidinil]amino]benzonitrilo

Country Status (21)

Country Link
EP (1) EP1632232B3 (enExample)
JP (1) JP4912309B2 (enExample)
CN (1) CN104586850A (enExample)
AT (1) ATE508748T1 (enExample)
BR (1) BRPI0514871A (enExample)
CY (3) CY1112249T1 (enExample)
DK (1) DK1632232T6 (enExample)
EA (1) EA013686B1 (enExample)
ES (1) ES2371442T7 (enExample)
FR (2) FR16C1023I1 (enExample)
HK (1) HK1210029A1 (enExample)
HU (2) HUS1600061I1 (enExample)
IL (1) IL181650A (enExample)
LT (2) LTC1632232I2 (enExample)
ME (1) ME01246B (enExample)
MX (1) MX2007002595A (enExample)
NI (1) NI200700068A (enExample)
NO (3) NO340654B1 (enExample)
PT (1) PT1632232E (enExample)
RS (1) RS51923B2 (enExample)
SI (1) SI1632232T1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
SI1981506T1 (sl) 2006-01-20 2013-08-30 Janssen R&D Ireland Dolgoročno zdravljenje infekcije HIV s TCM278
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
ES2524408T5 (es) * 2010-11-19 2022-04-25 Gilead Sciences Inc Composiciones terapéuticas que comprenden rilpivirina HCl y tenofovir disoproxil fumarato
AP2013006779A0 (en) * 2011-04-15 2013-03-31 Emcure Pharmaceuticals Ltd An improved rilpivirine process
EP2604593A1 (en) 2011-12-14 2013-06-19 Sandoz AG Polymorph of Rilpivirine hydrochloride and its use as antiviral
WO2013087794A1 (en) 2011-12-14 2013-06-20 Sandoz Ag Polymorph of rilpivirine hydrochloride and its use as antiviral
EP2628732A1 (en) * 2012-02-20 2013-08-21 Sandoz AG Novel crystalline form of rilpivirine hydrochloride
WO2013153161A2 (en) * 2012-04-11 2013-10-17 Sandoz Ag Novel polymorph of rilpivirine hydrochloride
WO2013153162A1 (en) * 2012-04-11 2013-10-17 Sandoz Ag Polymorph of rilpivirine hydrochloride
CN103570688B (zh) * 2012-07-19 2016-06-08 中国科学院上海药物研究所 2，5-二氨甲基吡嗪类化合物、其药物组合物、制备方法和用途
GR1008965B (el) * 2015-12-02 2017-02-28 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο σκευασμα που περιλαμβανει δαρουναβιρη και μεθοδος παρασκευης αυτου
RU2616267C1 (ru) * 2016-01-25 2017-04-13 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма индинавира немедленного высвобождения и способ ее получения
CN110191704A (zh) * 2016-10-24 2019-08-30 爱尔兰詹森科学公司 可分散组合物
JP7287906B2 (ja) * 2017-06-30 2023-06-06 ヴィーブ ヘルスケア カンパニー 組み合わせ並びにその使用及びそれによる治療
CN114392241B (zh) * 2022-01-10 2023-07-25 安徽贝克生物制药有限公司 一种利匹韦林片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307543B1 (en) * 1998-09-10 2001-10-23 Silicon Image, Inc. Bi-directional data transfer using two pair of differential lines as a single additional differential pair
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
AU2003266413B2 (en) * 2002-08-09 2009-04-02 Janssen Pharmaceutica N.V. Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
WO2004050068A1 (en) * 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
EA011164B1 (ru) * 2003-02-07 2009-02-27 Янссен Фармацевтика Н. В. Производные пиримидина для профилактики вич-инфекции

Also Published As

Publication number Publication date
ME01246B (me) 2013-06-20
RS51923B2 (sr) 2022-05-31
HUS1600060I1 (hu) 2017-01-30
NO2017065I1 (no) 2017-11-21
CY1112249T1 (el) 2015-12-09
JP2008511592A (ja) 2008-04-17
SI1632232T1 (sl) 2011-09-30
LTPA2016043I1 (lt) 2017-01-10
MX2007002595A (es) 2007-04-25
DK1632232T6 (da) 2022-04-19
HK1210029A1 (en) 2016-04-15
NO20071745L (no) 2007-04-02
BRPI0514871A (pt) 2008-06-24
NI200700068A (es) 2016-09-29
FR16C1025I2 (fr) 2025-11-21
LTC1632232I2 (lt) 2024-09-10
DK1632232T3 (da) 2011-08-22
JP4912309B2 (ja) 2012-04-11
IL181650A0 (en) 2007-07-04
ATE508748T1 (de) 2011-05-15
LTPA2016042I1 (lt) 2017-01-10
EP1632232A1 (en) 2006-03-08
FR16C1023I1 (fr) 2017-02-03
CY2016050I1 (el) 2017-07-12
NO2017063I1 (no) 2017-11-21
EA013686B1 (ru) 2010-06-30
NO340654B1 (no) 2017-05-22
EA200700536A1 (ru) 2007-08-31
ES2371442T3 (es) 2012-01-02
FR16C1025I1 (fr) 2017-02-03
CN104586850A (zh) 2015-05-06
IL181650A (en) 2012-08-30
RS51923B (sr) 2012-02-29
ES2371442T7 (es) 2022-05-12
CY2016051I1 (el) 2017-07-12
EP1632232B3 (en) 2022-03-30
EP1632232B1 (en) 2011-05-11
HUS1600061I1 (hu) 2017-01-30

Similar Documents

Publication Publication Date Title
LTPA2016042I1 (lt) 4[[4-[[4-(2-Cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrilo druska
WO2005037824A3 (de) Verfahren zur herstellung von aminocrotonylverbindungen
NO2014030I1 (no) (E)-4-[[4-[[4-(2-cyanoetenyl)-2,6-dimetylfenyl]-amino]-2-pyrimidinyl]-amino]-benzonitril("Rilpivirine") samt enhver terapeutisk form derav som er dekket av det aktuelle patentet så som farmasøytisk akseptable salter av Rilpivirie innbefattende hydrokloridsaltet av Rilpivirine, og emtricitabine.
AR023624A1 (es) Composiciones farmaceuticas que comprenden un inhibidor de hmg coa reductasa
WO2009007441A3 (en) Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile
PL373679A1 (en) Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
PL1632232T3 (pl) Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu
CR9032A (es) Fumarato de 4-((4-((4-(2-cianoetenil)-2,6-dimetilfenil)amino-2- pirimidinil)amino)benzonitrilo
UA92467C2 (ru) Гидрохлорид 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
SE0103476D0 (sv) New use
HRP20110563T1 (en) Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
UY27049A1 (es) Composiciones farmacéuticas